1. Home
  2. ERC vs QTTB Comparison

ERC vs QTTB Comparison

Compare ERC & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allspring Multi-Sector Income Fund

ERC

Allspring Multi-Sector Income Fund

N/A

Current Price

$8.31

Market Cap

238.7M

Sector

Finance

ML Signal

N/A

Logo Q32 Bio Inc.

QTTB

Q32 Bio Inc.

N/A

Current Price

$8.72

Market Cap

265.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ERC
QTTB
Founded
2003
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
238.7M
265.2M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
ERC
QTTB
Price
$8.31
$8.72
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $39.67
AVG Volume (30 Days)
90.6K
★ 341.5K
Earning Date
01-01-0001
11-04-2026
Dividend Yield
★ 8.37%
N/A
EPS Growth
N/A
★ 136.78
EPS
★ 0.72
N/A
Revenue
N/A
★ $53,737,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$11.60
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.31
$1.91
52 Week High
$9.56
$23.57

Technical Indicators

Market Signals
Indicator
ERC
QTTB
Relative Strength Index (RSI) 35.13 46.47
Support Level N/A $8.23
Resistance Level $9.20 $9.41
Average True Range (ATR) 0.11 0.54
MACD -0.02 0.02
Stochastic Oscillator 7.14 39.29

Price Performance

Historical Comparison
ERC
QTTB

About ERC Allspring Multi-Sector Income Fund

Allspring Multi-Sector Income Fund is a closed-end investment management company. The company's core business is to secure a high level of income for its investors consistent with limiting its overall exposure to domestic interest rate risk. It invests in U.S. dollar-denominated below investment-grade bonds, debentures, and other income obligations, including loans and preferred stocks, developed and emerging market debt securities, including obligations of foreign governments or governmental entities, foreign corporations, or supranational agencies denominated in various currencies, asset backed securities and investment grade corporate bonds.

About QTTB Q32 Bio Inc.

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to restore healthy immune balance in patients with alopecia areata (AA) and other autoimmune and inflammatory diseases driven by immune dysfunction. Its product candidate, bempikibart (ADX 914), is a fully human anti-interleukin 7 receptor alpha (IL-7R) antagonist monoclonal antibody designed to block signaling mediated by interleukin 7 (IL 7) and thymic stromal lymphopoietin (TSLP) and re-regulate adaptive immune function. The company has completed two Phase 2a clinical trials evaluating bempikibart, SIGNAL AA Part A for the treatment of alopecia areata and SIGNAL AD for the treatment of atopic dermatitis (AD).

Share on Social Networks: